top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Recent Advances and Clinical Outcomes of Kidney Transplantation : Volume 2
Recent Advances and Clinical Outcomes of Kidney Transplantation : Volume 2
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (270 p.)
Soggetto topico Medicine
Soggetto non controllato malondialdehyde
oxidative stress
new-onset diabetes
renal transplantation
BK virus
BK virus nephropathy
kidney allograft
transplantation
Alport syndrome
children
autosomal dominant polycystic kidney disease
epidemiology
hospitalization
kidney transplantation
subarachnoid hemorrhage
malignancy
post-transplant malignancy
renal cell carcinoma
meta-analysis
systematic reviews
tacrolimus
C/D-ratio
pharmacokinetics
opportunistic infection
allograft survival
urological complications
ureteric stent
urinary tract infection
timing of removal
living donor
ethnicity
age
obesity
genetic relationship donor/recipient
atypical hemolytic uremic syndrome
eculizumab
glucose intolerance
insulin secretion
insulin resistance
oral glucose tolerance test
healthy subject
hyperchloremia
kidney graft dysfunction
living donor kidney transplantation
Uropathogenic E. coli
UPEC
phylogeny
genomics
antibiotic resistance
virulence traits
night-time renal transplantation
graft survival
patient survival/outcome
surgical complications
acute rejection
lymphocyte
CD45RC
Belatacept
cardiovascular high risk
outcome
machine perfusion
organ preservation
temperature
hypothermic
normothermic
transplant
proton-pump inhibitors
iron
iron deficiency
polyomavirus
BKV
kidney
glomerulus
BKVAN
nephropathy
fluid management
delayed graft function
goal-directed fluid therapy
calcineurin inhibitor nephrotoxcity
C/D ratio
tacrolimus metabolism
ADPKD
native nephrectomy
patient outcome
perioperative complications
epidermal growth factor
creatinine
graft failure
new onset diabetes after renal transplantation
single nucleotide polymorphisms
urinary biomarkers
α-GST
π-GST
nephrotoxicity
urinary excretion of N1-methylnicotinamide
mortality
niacin status
dietary intake
tryptophan
vitamin B3
Kidney transplant
vitamin C
cancer mortality
mycophenolic acid
immunosuppression
plasmapheresis
oxalate
hyperoxaluria
kidney transplant recipients
post-transplantation diabetes mellitus
all-cause mortality
cardiovascular mortality
infectious mortality
magnesium
hypomagnesaemia
cancer
kidney transplant
survival
living kidney donation
living-donor kidney transplantation
beliefs
inequity
ischemia reperfusion injury
innate immune system
adaptive immune system
apoptosis
necrosis
hypoxic inducible factor
endothelial dysfunction
proton pump inhibitor
transplant rejection
GFR
insulin-like growth factor 1
growth hormone
muscle mass
patient survival
physical activity
renal transplant recipients
kidney transplant (KT)
donor-specific antibodies (DSA)
C3d-binding assay
antibody-mediated rejection (AMR)
arsenic
diet
fish consumption
post-transplant diabetes mellitus
N1-methyl-2-pyridone-5-carboxamide
N1-methylnicotinamide
urinary excretion
kidney function
biomarker
branched chain amino acids
posttransplant diarrhea
methanogenesis
Methanosphaera stadtmanae
mucins
sulfate-reducing bacteria
acute humoral rejection
first-line therapy
outcomes
proteasome inhibitor
renal transplant
transplant recipients
calcineurin inhibitors
FK506
pharmacokinetic
fast tacrolimus metabolizers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Recent Advances and Clinical Outcomes of Kidney Transplantation
Record Nr. UNINA-9910557787303321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances and Clinical Outcomes of Kidney Transplantation
Recent Advances and Clinical Outcomes of Kidney Transplantation
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (342 p.)
Soggetto topico Medicine
Soggetto non controllato malondialdehyde
oxidative stress
new-onset diabetes
renal transplantation
BK virus
BK virus nephropathy
kidney allograft
transplantation
Alport syndrome
children
autosomal dominant polycystic kidney disease
epidemiology
hospitalization
kidney transplantation
subarachnoid hemorrhage
malignancy
post-transplant malignancy
renal cell carcinoma
meta-analysis
systematic reviews
tacrolimus
C/D-ratio
pharmacokinetics
opportunistic infection
allograft survival
urological complications
ureteric stent
urinary tract infection
timing of removal
living donor
ethnicity
age
obesity
genetic relationship donor/recipient
atypical hemolytic uremic syndrome
eculizumab
glucose intolerance
insulin secretion
insulin resistance
oral glucose tolerance test
healthy subject
hyperchloremia
kidney graft dysfunction
living donor kidney transplantation
Uropathogenic E. coli
UPEC
phylogeny
genomics
antibiotic resistance
virulence traits
night-time renal transplantation
graft survival
patient survival/outcome
surgical complications
acute rejection
lymphocyte
CD45RC
Belatacept
cardiovascular high risk
outcome
machine perfusion
organ preservation
temperature
hypothermic
normothermic
transplant
proton-pump inhibitors
iron
iron deficiency
polyomavirus
BKV
kidney
glomerulus
BKVAN
nephropathy
fluid management
delayed graft function
goal-directed fluid therapy
calcineurin inhibitor nephrotoxcity
C/D ratio
tacrolimus metabolism
ADPKD
native nephrectomy
patient outcome
perioperative complications
epidermal growth factor
creatinine
graft failure
new onset diabetes after renal transplantation
single nucleotide polymorphisms
urinary biomarkers
α-GST
π-GST
nephrotoxicity
urinary excretion of N1-methylnicotinamide
mortality
niacin status
dietary intake
tryptophan
vitamin B3
Kidney transplant
vitamin C
cancer mortality
mycophenolic acid
immunosuppression
plasmapheresis
oxalate
hyperoxaluria
kidney transplant recipients
post-transplantation diabetes mellitus
all-cause mortality
cardiovascular mortality
infectious mortality
magnesium
hypomagnesaemia
cancer
kidney transplant
survival
living kidney donation
living-donor kidney transplantation
beliefs
inequity
ischemia reperfusion injury
innate immune system
adaptive immune system
apoptosis
necrosis
hypoxic inducible factor
endothelial dysfunction
proton pump inhibitor
transplant rejection
GFR
insulin-like growth factor 1
growth hormone
muscle mass
patient survival
physical activity
renal transplant recipients
kidney transplant (KT)
donor-specific antibodies (DSA)
C3d-binding assay
antibody-mediated rejection (AMR)
arsenic
diet
fish consumption
post-transplant diabetes mellitus
N1-methyl-2-pyridone-5-carboxamide
N1-methylnicotinamide
urinary excretion
kidney function
biomarker
branched chain amino acids
posttransplant diarrhea
methanogenesis
Methanosphaera stadtmanae
mucins
sulfate-reducing bacteria
acute humoral rejection
first-line therapy
outcomes
proteasome inhibitor
renal transplant
transplant recipients
calcineurin inhibitors
FK506
pharmacokinetic
fast tacrolimus metabolizers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557632603321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting Myeloid Cells to Fight Cancer
Targeting Myeloid Cells to Fight Cancer
Autore Hollmén Maija
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (150 p.)
Soggetto topico Medicine
Immunology
Soggetto non controllato tumor microenvironment
monocyte
macrophage
neutrophil
immunosuppression
immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557541803321
Hollmén Maija  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Autore Moriggl Richard
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (578 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato multiple myeloma
STAT3
S3I-1757
nanoparticle
CD38
siRNA/RNAi
polyethylenimine
PEI
lipopolyplex
siRNA delivery
glioma
glioblastoma
STAT5
AKT
ERK1/2
prolactin
androgens
prostate cancer
knockout
escape mechanisms
stem/progenitor cells
cell hierarchy
cancer
CD4+ T cells
CD8+ T cells
myeloid cells
immune check point
hepatitis C virus (HCV)
cirrhosis
hepatocellular carcinoma (HCC)
endoplasmic reticulum (ER) stress
oxidative stress (OS)
unfolded protein response (UPR)
microRNA-122 (miR-122)
nuclear factor erythroid 2-related factor 2 (NRF2)
signal transducer and activator of transcription 3 (STAT3)
hepatocyte nuclear factor 4 alpha (HNF4A)
solid cancers
cell cycle
apoptosis
inflammation
mitochondria
stemness
tumor suppression
melanoma
autoimmune disease
immunotherapy
tumor-immune cell interactions
breast cancer
PD-L1
M2 macrophages
NK cells
STAT3 inhibitor XIII
hedging
transaction costs
dynamic programming
risk management
post-decision state variable
cancer progression
cancer-stem cell
cytokine
therapy resistance
metastasis
immunosuppression
tumor microenvironment
proliferation
tyrosine kinase 2
JAK family of protein tyrosine kinases
signal transducer and activator of transcription
cytokine receptor signaling
gain-of-function mutation
tumorigenesis
ADAM17
interleukin-6
trans-signaling
epidermal growth factor receptor (EGF-R)
shedding
metalloprotease
tumor necrosis factor alpha (TNFα)
inflammation associated cancer
colon cancer
lung cancer
SH2 domain
mutations
autosomal-dominant hyper IgE syndrome
inflammatory hepatocellular adenomas
T-cell large granular lymphocytic leukemia
T-cell prolymphocytic leukemia
growth hormone insensitivity syndrome
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
targeting
tumor-associated macrophages
adoptive T cell therapy
immune suppression
STAT transcription factors
JAK
STAT
T-PLL
T-cell leukemia
meta-analysis
STAT5B signaling
small-molecule inhibitors
cancer models
companion animals
comparative oncology
pharmacological inhibitor
STAT5 signaling
chemotherapy resistance
myeloid leukemia
heat shock proteins
chaperones
stabilization
targeted therapy
ovarian cancer
hematopoietic cancers
therapeutic targeting
pharmacological inhibitors
mTOR
Bone Marrow Failure Syndromes
lymphocytes
lymphoma
T-cells
RHOA
NGS
MPN
JAK2 V617F
neoplastic stem cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Moriggl Richard  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Toxic Metals, Chronic Diseases and Related Cancers
Toxic Metals, Chronic Diseases and Related Cancers
Autore Satarug Soisungwan
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (318 p.)
Soggetto topico Public health & preventive medicine
Soggetto non controllato Trace elements
hair
children
hazardous waste incinerator
Constantí (Catalonia, Spain)
blood lead level
boatyard
childhood
lead poisoning
fishing community
lead weights
β2-microglobulin
cadmium
creatinine clearance
glomerular filtration
N-acetyl-β-d-glucosaminidase
nephron mass
nephrotoxicity
trace elements
autopsy tissues
temporal trends
creatinine excretion
glomerular filtration rate
lead
kidney
endocytosis
metallothionein
flow cytometry
proximal tubule epithelial cells
OGTT
minimal model
glucose response mechanism
genotoxicity
aluminum chloride
rats
food
farmer
PTWI (provisional tolerable monthly intake)
TWI (tolerable weekly intake)
Monte Carlo simulation
mercury
obesogen
lipid profiles
hyperlipidemia
elevated liver enzymes
hexavalent chromium [Cr(VI)]
mitochondrial fragmentation
dynamin-related protein 1 (Drp1)
mitochondrial respiratory chain complex I (MRCC I)
reactive oxygen species (ROS)
blood lead
cellular immunity
phagocytosis
humoral munity
immunosuppression
insulin
diabetes
hyperglycemia
hyperinsulinemia
lipogenic
β-cell toxicity
stroke
cerebrovascular accident
heavy metal
rare earth element
case-control study
mortality
lifetime cadmium intake
renal diseases
urinary cadmium
a follow-up study
diet
kidney function
chronic kidney disease
threshold limit
tolerable intake level
heavy metals
birth weight
preterm birth
diet pattern
Mediterranean diet
pregnancy
toxic metals
reproduction
testicular and ovarian structure
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580214603321
Satarug Soisungwan  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui